A phase 1 trial of GSL (gemcitabine, S-1, LV) combination therapy in advanced pancreatic cancer.
Yousuke Nakai
No relevant relationships to disclose
Hiroyuki Isayama
No relevant relationships to disclose
Takashi Sasaki
No relevant relationships to disclose
Kei Saito
No relevant relationships to disclose
Naminatsu Takahara
No relevant relationships to disclose
Suguru Mizuno
No relevant relationships to disclose
Tsuyoshi Hamada
No relevant relationships to disclose
Koji Miyabayashi
No relevant relationships to disclose
Keisuke Yamamoto
No relevant relationships to disclose
Hirofumi Kogure
No relevant relationships to disclose
Natsuyo Yamamoto
No relevant relationships to disclose
Kenji Hirano
No relevant relationships to disclose
Hideaki Ijichi
No relevant relationships to disclose
Keisuke Tateishi
No relevant relationships to disclose
Minoru Tada
No relevant relationships to disclose
Kazuhiko Koike
No relevant relationships to disclose